Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia

被引：10

作者：

Beresford, Rohan ^{[1
]}

Dolot, Virginia ^{[1
]}

Foo, Hong ^{[1
,2
]}

机构：

[1] NSW Hlth Pathol South West Sydney, Dept Microbiol & Infect Dis, Sydney, NSW, Australia

[2] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia

来源：

MEDICAL MYCOLOGY CASE REPORTS | 2019年 / 24卷

关键词：

Aspergillosis; Ibrutinib; Cerebral abscess; Chronic lymphocytic leukemia;

D O I：

10.1016/j.mmcr.2019.02.005

中图分类号：

R-3 [医学研究方法]; R3 [基础医学];

学科分类号：

1001 ;

摘要：

Cerebral abscess due to Aspergillus species is a relatively uncommon presentation, even amongst immunocompromised patients. However it is increasingly being recognized as a complication of ibrutinib therapy in patients with chronic lymphocytic leukemia. We present a case of cerebral abscesses caused by Aspergillus felis in a patient receiving ibrutinib for chronic lymphocytic leukemia.

引用

页码：27 / 29

页数：3

共 50 条

[31] Characteristics and Clinical Outcomes of Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Receiving Ibrutinib for ≥5 Years in the RESONATE-2 Study
Woyach, Jennifer A.
Barr, Paul M.
Kipps, Thomas J.
Barrientos, Jacqueline C.
Ahn, Inhye E.
Ghia, Paolo
Girardi, Vincent
Hsu, Emily
Jermain, Mandy
Burger, Jan A.
CANCERS, 2023, 15 (02)
[32] Cutaneous Mucormycosis Following a Bullous Pemphigoid Flare in a Chronic Lymphocytic Leukemia Patient on Ibrutinib
Stein, Matthew K.
Karri, Saradasri
Reynolds, Jackson
Owsley, Jeff
Wise, Austin
Martin, Mike G.
Zare, Fereshteh
WORLD JOURNAL OF ONCOLOGY, 2018, 9 (02) : 62 - 65
[33] Incidence of invasive fungal infections in patients with chronic lymphocytic leukemia receiving ibrutinib within the veteran's healthcare administration
Walker, Cassandra
Horowitz, Amy
Nooruddin, Zohra
Frei, Christopher R.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2024, 30 (04) : 673 - 677
[34] Severe arthritic syndrome due to ibrutinib use for chronic lymphocytic leukemia
Dasanu, Constantin A.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (04) : 1003 - 1005
[35] Ibrutinib in chronic lymphocytic leukemia and B cell malignancies
Brown, Jennifer R.
LEUKEMIA & LYMPHOMA, 2014, 55 (02) : 263 - 269
[36] Infection with ibrutinib in patients with chronic lymphocytic leukemia: How strong is the association?
Ball, Somedeb
Vutthikraivit, Wasawat
Maiti, Abhishek
Short, Nicholas J.
EUROPEAN JOURNAL OF HAEMATOLOGY, 2018, 101 (03) : 418 - 420
[37] Ibrutinib in Chronic Lymphocytic Leukemia: Clinical Applications, Drug Resistance, and Prospects
Zhou, Hong
Hu, Pan
Yan, Xiyue
Zhang, Yaping
Shi, Wenyu
ONCOTARGETS AND THERAPY, 2020, 13 : 4877 - 4892
[38] Ibrutinib in the treatment of chronic lymphocytic leukemia: 5 years on
Molica, Stefano
Matutes, Estella
Tam, Constantine
Polliack, Aaron
HEMATOLOGICAL ONCOLOGY, 2020, 38 (02) : 129 - 136
[39] Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia
Forestieri, Gabriela
Terzi di Bergamo, Lodovico
Deodato, Marina
Frustaci, Anna Maria
Moia, Riccardo
Deambrogi, Clara
Rasi, Silvia
Autore, Francesco
Merli, Michele
Mattarucchi, Roberta
Fahrni, Gaby
Scarfo', Lydia
Gussetti, Daniela
Bulian, Pietro
Zanatta, Annagiulia
Spina, Valeria
Bruscaggin, Alessio
Pini, Katia
Piffaretti, Deborah
Pirosa, Maria Cristina
Salehi, Matin
Marques de Almeida, Joyce
Passweg, Jakob
Cavalli, Franco
Zucca, Emanuele
Gerber, Bernhard
Stussi, Georg
Gattei, Valter
Ghia, Paolo
Gregor, Michael
Passamonti, Francesco
Laurenti, Luca
Gaidano, Gianluca
Tedeschi, Alessandra
Rossi, Davide
Condoluci, Adalgisa
HEMATOLOGICAL ONCOLOGY, 2022, 40 (05) : 1100 - 1104
[40] Invasive Genitourinary Aspergillosis in a Patient With Chronic Lymphocytic Leukemia Treated With Venetoclax: Case Report and Review of the Literature
Albin, Owen R.
Soper, Nathaniel
Khurana, Irina
Kauffman, Carol A.
OPEN FORUM INFECTIOUS DISEASES, 2019, 6 (11):

← 1 2 3 4 5 →